Jason Park joined Flagship Pioneering in 2015 and focuses on life science investments and company creation. He leads a team of entrepreneurial scientists to develop the science, intellectual property, and business strategy that form the foundation of Flagship’s next breakthrough start-ups. He also leads the firm’s activities in New York City.
Prior to joining Flagship, Jason was with the Boston Consulting Group where he led teams in the U.S., India, and Europe across a broad variety of topics, including R&D and portfolio strategy, biopharmaceutical manufacturing, strategic and commercial due diligence, and Global Health. Previously, Jason was a director at an early stage biotech start-up focused on targeted drug delivery as well as the co-founder of an internet advertising firm.
Jason earned a Ph.D., an M.S. and a B.S. in biomedical engineering from Yale University. His research focused on the use of nanotechnology for immunomodulatory purposes and he has co-authored multiple book chapters and more than a dozen publications in journals such as Nature and Cell.